======= AKAP8L ======= == Gene Information == * **Official Symbol**: AKAP8L * **Official Name**: A-kinase anchoring protein 8 like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26993|26993]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9ULX6|Q9ULX6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AKAP8L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AKAP8L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609475|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Could play a role in constitutive transport element (CTE)-mediated gene expression by association with DHX9. Increases CTE-dependent nuclear unspliced mRNA export (PubMed:10748171, PubMed:11402034). Proposed to target PRKACA to the nucleus but does not seem to be implicated in the binding of regulatory subunit II of PKA (PubMed:10761695, PubMed:11884601). May be involved in nuclear envelope breakdown and chromatin condensation. May be involved in anchoring nuclear membranes to chromatin in interphase and in releasing membranes from chromating at mitosis (PubMed:11034899). May regulate the initiation phase of DNA replication when associated with TMPO isoform Beta (PubMed:12538639). Required for cell cycle G2/M transition and histone deacetylation during mitosis. In mitotic cells recruits HDAC3 to the vicinity of chromatin leading to deacetylation and subsequent phosphorylation at 'Ser-10' of histone H3; in this function seems to act redundantly with AKAP8 (PubMed:16980585). May be involved in regulation of pre-mRNA splicing (PubMed:17594903). {ECO:0000269|PubMed:10748171, ECO:0000269|PubMed:11034899, ECO:0000269|PubMed:11402034, ECO:0000269|PubMed:11884601, ECO:0000269|PubMed:12538639, ECO:0000269|PubMed:16980585, ECO:0000305|PubMed:10761695}. (Microbial infection) Can synergize with DHX9 to activate the CTE-mediated gene expression of type D retroviruses. {ECO:0000269|PubMed:11402034}. |AKAP95| |regulation of mRNA export from nucleus| |regulation of ribonucleoprotein complex localization| |DEAD/H-box RNA helicase binding| |regulation of histone phosphorylation| |regulation of RNA export from nucleus| |lamin binding| |nuclear envelope disassembly| |membrane disassembly| |regulation of nucleobase-containing compound transport| |mitotic chromosome condensation| |positive regulation of histone deacetylation| |protein kinase A regulatory subunit binding| |positive regulation of protein deacetylation| |regulation of histone deacetylation| |regulation of protein export from nucleus| |regulation of protein deacetylation| |chromosome condensation| |nuclear envelope organization| |positive regulation of histone modification| |PML body| |positive regulation of chromatin organization| |regulation of nucleocytoplasmic transport| |mitotic sister chromatid segregation| |nuclear matrix| |histone deacetylase binding| |chromatin| |nucleus organization| |cell cycle G2/M phase transition| |sister chromatid segregation| |regulation of histone modification| |mitotic nuclear division| |ribonucleoprotein complex| |positive regulation of chromosome organization| |DNA packaging| |regulation of chromatin organization| |nuclear chromosome segregation| |regulation of intracellular protein transport| |chromosome segregation| |cell cycle phase transition| |nuclear division| |DNA conformation change| |organelle fission| |regulation of chromosome organization| |regulation of intracellular transport| |RNA splicing| |cellular component disassembly| |nuclear speck| |endomembrane system organization| |mRNA processing| |regulation of cellular protein localization| |mitotic cell cycle process| |positive regulation of organelle organization| |mitotic cell cycle| |mRNA metabolic process| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |membrane organization| |RNA processing| |regulation of cellular localization| |cell cycle process| |regulation of protein localization| |chromosome organization| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |positive regulation of protein modification process| |regulation of organelle organization| |cell cycle| |RNA binding| |regulation of protein phosphorylation| |DNA binding| |positive regulation of transcription, DNA-templated| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp90|WYE-354 6μM R02 exp90]]|-1.92| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-1.9| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-1.78| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|1.71| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|1.76| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|2.06| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17397 * **Expression level (log2 read counts)**: 6.24 {{:chemogenomics:nalm6 dist.png?nolink |}}